ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Yuan Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3777-140X; OpenAlex author ID A5059576218. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma ce… Co-author PMID 33520371 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yingbin Liu · 1 shared paper, 2021 · strength 0.15
- Paper Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabin… PMID 33520371 ↗
Liuqing Yang · 1 shared paper, 2021 · strength 0.15
- Paper Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabin… PMID 33520371 ↗
Dihua Yu · 1 shared paper, 2021 · strength 0.15
- Paper Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabin… PMID 33520371 ↗
Mien‐Chie Hung · 1 shared paper, 2021 · strength 0.15
- Paper Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabin… PMID 33520371 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.